High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series - 28/05/21
, Kyle M. DeWitt, PharmD a, Blake A. Porter, PharmD a, Michael Sheeser, MD b, Eike Blohm, MD b, Mark Bisanzo, MD bAbstract |
Sympathetic crashing acute pulmonary edema (SCAPE) describes the most severe presentation of acute heart failure (AHF). Immediate intervention is required to prevent hemodynamic decompensation and endotracheal intubation. Although high-dose nitroglycerin (>100 μg/min) has been described for this clinical scenario in limited case reports, the concern for adverse effects such as hypotension and syncope limit providers comfortability in initiating nitroglycerin at these doses. Described here is a case series of four patients who safely and effectively received high-dose nitroglycerin infusions for the management of SCAPE.
Le texte complet de cet article est disponible en PDF.Keywords : Sympathetic crashing acute pulmonary edema (SCAPE), High-dose nitroglycerin, Flash pulmonary edema, Acute heart failure (AHF), Bilevel positive airway pressure (BPAP)
Plan
| ☆ | Presented: This article/case has not been presented to any organization or at any meeting. |
Vol 44
P. 262-266 - juin 2021 Retour au numéro
Article précédent
- Topiramate: A novel protective agent against ischemia reperfusion-induced oxidative injury after testicular torsion/detorsion
- Abbas Jafari, Hojat Ghasemnejad-Berenji, Mohadeseh Nemati, Morteza Ghasemnejad-Berenji
- Validation of a decision rule to predict patients at low risk of variceal upper gastrointestinal hemorrhage
- Brian E. Driver, Gabriella Horton, Alan Barkun, Myriam Martel, Lauren R. Klein
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?